Legend Biotech (LEGN) EBT Margin: 2019-2025
Historic EBT Margin for Legend Biotech (LEGN) over the last 7 years, with Sep 2025 value amounting to -14.35%.
- Legend Biotech's EBT Margin rose 6111.00% to -14.35% in Q3 2025 from the same period last year, while for Sep 2025 it was -30.79%, marking a year-over-year increase of 4758.00%. This contributed to the annual value of -25.21% for FY2024, which is 15720.00% up from last year.
- Latest data reveals that Legend Biotech reported EBT Margin of -14.35% as of Q3 2025, which was up 70.68% from -48.93% recorded in Q2 2025.
- In the past 5 years, Legend Biotech's EBT Margin registered a high of 21,719.15% during Q4 2024, and its lowest value of -184,752.84% during Q4 2023.
- Moreover, its 3-year median value for EBT Margin was -63.61% (2024), whereas its average is -14,903.72%.
- In the last 5 years, Legend Biotech's EBT Margin plummeted by 18,426,168bps in 2023 and then spiked by 20,647,200bps in 2024.
- Quarterly analysis of 5 years shows Legend Biotech's EBT Margin stood at -226.53% in 2021, then crashed by 26,464bps to -491.16% in 2022, then plummeted by 18,426,168bps to -184,752.84% in 2023, then soared by 20,647,200bps to 21,719.15% in 2024, then spiked by 6,111bps to -14.35% in 2025.
- Its last three reported values are -14.35% in Q3 2025, -48.93% for Q2 2025, and -50.82% during Q1 2025.